-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Initiates Coverage On Nasus Pharma with Buy Rating, Announces Price Target of $7

Benzinga·10/30/2026 13:32:25
Listen to the news
Maxim Group analyst Naz Rahman initiates coverage on Nasus Pharma (AMEX:NSRX) with a Buy rating and announces Price Target of $7.